66 related articles for article (PubMed ID: 25575811)
1. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer.
Clune S; Awolade P; Zhou Q; Esquer H; Matter B; Kearns JT; Kellett T; Akintayo DC; Kompella UB; LaBarbera DV
Biomed Pharmacother; 2024 Jan; 170():116037. PubMed ID: 38128184
[TBL] [Abstract][Full Text] [Related]
2. CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell Reprogramming.
Jiang BH; Chen WY; Li HY; Chien Y; Chang WC; Hsieh PC; Wu P; Chen CY; Song HY; Chien CS; Sung YJ; Chiou SH
Stem Cells; 2015 Oct; 33(10):2961-72. PubMed ID: 26201266
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells.
Cusimano A; Puleio R; D'Alessandro N; Loria GR; McCubrey JA; Montalto G; Cervello M
Oncotarget; 2015 Jan; 6(3):1707-22. PubMed ID: 25596737
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SCYL1 Is Associated with Progression of Breast Cancer.
Sun A; Tian X; Yang W; Lin Q
Curr Oncol; 2022 Sep; 29(10):6922-6932. PubMed ID: 36290821
[TBL] [Abstract][Full Text] [Related]
6. Chromodomain-helicase-DNA-binding protein 1-like (CHD1L) silencing inhibits gastric cancer cell proliferation, invasion, and migration.
Li D; Li C; Wang Y; Wang Y; Li Q; Wang L
Transl Cancer Res; 2020 Nov; 9(11):6660-6671. PubMed ID: 35117276
[TBL] [Abstract][Full Text] [Related]
7. Diversity roles of CHD1L in normal cell function and tumorigenesis.
Xiong X; Lai X; Li A; Liu Z; Ma N
Biomark Res; 2021 Mar; 9(1):16. PubMed ID: 33663617
[TBL] [Abstract][Full Text] [Related]
8. CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer.
Wang W; Wu J; Fei X; Chen W; Li Y; Shen K; Zhu L
Am J Transl Res; 2019; 11(3):1581-1592. PubMed ID: 30972184
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
[TBL] [Abstract][Full Text] [Related]
10. KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
Zhong Y; Yang J; Xu WW; Wang Y; Zheng CC; Li B; He QY
Oncogene; 2017 Nov; 36(44):6177-6189. PubMed ID: 28869606
[TBL] [Abstract][Full Text] [Related]
11. In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents.
Shrum B; Costello P; McDonald W; Howlett C; Donnelly M; McAlister VC
Hepatobiliary Surg Nutr; 2016 Jun; 5(3):204-8. PubMed ID: 27275461
[TBL] [Abstract][Full Text] [Related]
12. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
[TBL] [Abstract][Full Text] [Related]
13. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.
Wang J; Liu M; Chen L; Chan TH; Jiang L; Yuan YF; Guan XY
Oncotarget; 2015 Jan; 6(3):1618-30. PubMed ID: 25575811
[TBL] [Abstract][Full Text] [Related]
15. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
[TBL] [Abstract][Full Text] [Related]
16. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
17. CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
Wang G; Zhang X; Cheng W; Mo Y; Chen J; Cao Z; Chen X; Cui H; Liu S; Huang L; Liu M; Ma L; Ma NF
Cell Death Dis; 2021 Sep; 12(10):891. PubMed ID: 34588420
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.
Chen L; Chan TH; Guan XY
Acta Pharmacol Sin; 2010 Sep; 31(9):1165-71. PubMed ID: 20676120
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
